Helium/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: A randomized, placebo-controlled trial

Pediatric Critical Care Medicine

Volumn 11, Issue 3, 2010, Pages 356-361

  Bigham, Michael T ^a   Jacobs, Brian R ^b   Monaco, Marie A ^c   Brilli, Richard J ^d   Wells, Dan ^c   Conway, Edward M ^c   Pettinichi, Scott ^c   Wheeler, Derek S ^c  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Asthma; Heliox; Helium oxygen; Hospitalized; Length of stay; Pediatric; Status asthmaticus

Indexed keywords

CORTICOSTEROID; HELIUM; IPRATROPIUM BROMIDE; MAGNESIUM SULFATE; OXYGEN; PLACEBO; SALBUTAMOL; TERBUTALINE;

ABDOMINAL PAIN; ACIDOSIS; AEROSOL; AGITATION; ANEMIA; ARTICLE; ASTHMA; ASTHMATIC STATE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG INTERMITTENT THERAPY; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERCHLOREMIA; HYPERGLYCEMIA; HYPERNATREMIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOTENSION; HYPOXEMIA; LENGTH OF STAY; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; NAUSEA; NEBULIZATION; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; TACHYPNEA; THORAX PAIN; VOMITING;

EID: 77952313401     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181c5163f     Document Type: Article

References (26)

1. Akinbami L: The state of childhood asthma, United States, 1980-2005. Adv Data 2006;381:1-24
2. Smith DH, Malone DC, Lawson KA, et al: A national estimate of the economic costs of asthma. Am J Resp Crit Care Med 1997;156:787-793
3. Lozano P, Sullivan SD, Smith DH, et al: The economic burden of asthma in US children: Estimates from the National Medical Expenditure Survey. J Allergy Clin Immunol 1999;104:957-963
4. Goodman DC, Stukel TA, Chang C: Trends in pediatric asthma hospitalization rates: Regional and socioeconomic differences. Pediatrics 1998;101:208-213
5. Mannino DM, Homa DM, Akinbami LJ, et al: Surveillance for asthma: United States, 1980-1999. Mor Mortal Wkly Rep CDC Surveill Summ 2002;51:1-13
6. Mannino DM, Homa DM, Pertowski CA, et al: Surveillance for asthma: United States, 1960-1995. Morb Mortal Wkly Rep CDC Surveill Summ 1998;47:1-27
7. Sly RM: Decrease in asthma mortality in the United States. Ann Allergy Asthma Immunol 2000;85:121-127
8. Wennergren G, Strannegard IL: Asthma hospitalizations continue to decrease in schoolchildren but hospitalization rates for wheezing remain high in young children. Acta Paediatr 2002;91:1239-1245
9. Akinbami LJ, Schoendorf KC: Trends in childhood asthma: Prevalence, health care utilization, and mortality. Pediatrics 2002;110:315-322
10. Weinberger M: Seventeen years of asthma guidelines: Why hasn't the outcome improved for children? J Pediatr 2009;154:786-788
11. Akinbami LJ, Moorman JE, Garbe PL, et al: Status of childhood asthma in the United States, 1980-2007. Pediatrics 2009;123:S131-S145
12. Barach AL: The therapeutic use of helium. JAMA 1935;107:1273-1280
13. Chan-Yeung M, Aboud R, Tsao MS, et al: Effect of helium on maximal expiratory flow in patients with asthma before and during induced bronchoconstriction. Am Rev Respir Dis 1976;113:433-443
14. Kim IK, Saville AL, Sikes KL, et al: Helioxdriven albuterol nebulization for asthma exacerbations: An overview. Respir Care 2006;51:613-618
15. Rodrigo G, Pollack C, Rodrigo C, et al: Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; CD002884
16. Carter ER, Webb CR, Moffitt DR: Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial. Chest 1996;109:1256-1261
17. Kim IK, Phrampus E, Venkataraman S, et al: Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: A randomized, controlled trial. Pediatrics 2005;116:1127-33
18. Rivera ML, Kim TY, Stewart GM, et al: Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: A blinded, randomized controlled trial. Am J Emerg Med 2006;24:38-42
19. Becker AB, Nelson NA, Simons F E R: The pulmonary index: Assessment of a clinical score for asthma. Am J Dis Child 1984;138:574-576
20. DiGiulio GA, Kercsmar CM, Krug SE, et al: Hospital treatment of asthma: Lack of benefit from theophylline given in addition to nebulized albuterol and intravenously administered corticosteroid. J Pediatr 1993;122:464-469
21. Papo MC, Frank J, Thompson AE: A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21:1479-1486
22. Craig VL, Bigos D, Brilli RJ: Efficacy and safety of continuous albuterol nebulization in children with severe status asthmaticus. Pediatr Emerg Care 1996;12:1-5
23. Corcoran TE, Gamard S: Development of aerosol drug delivery with helium oxygen gas mixtures. J Aerosol Med 2004;17:299-309
24. Chang LH, Honiden S, Haithcock JA, et al: Utilization of bronchodilators in ventilated patients without obstructive airways disease. Respir Care 2007;52:154-158
25. Cook P, Scarfone RJ, Cook RT: Adenosine in the termination of albuterol-induced supraventricular tachycardia. Ann Emerg Med 1994;24:316-319
26. Duane M, Chandran L, Morelli PJ: Recurrent supraventricular tachycardia as a complication of nebulized albuterol treatment. Clin Pediatr (Phila) 2000;39:673-677